Product Information

TOBRAMYCIN 300 MG/5 ML AMPULE is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $1.0392 per ML under NDC 68180096256. Its NADAC has been published 232 times since Apr 13, 2022.

FDA first approved this application on Mar 22, 2017. Its Orange Book therapeutic-equivalence code is AN.

TOBRAMYCIN 300 MG/5 ML AMPULE

Tobramycin
$1.0392per ML

Strength

300 mg/5mL

NDC

68180096256

Classification

Generic

Dosage Form

SOLUTION

Route

RESPIRATORY (INHALATION)

Effective Date

11/18/2026

Active Ingredients

TOBRAMYCIN

Approval Type

Generic (ANDA)

FDA Application

ANDA208964

FDA Approved

3/22/2017

TE Code

AN

On Market Since

6/12/2018

Pharmacological Classes

Price Statistics

The NADAC for TOBRAMYCIN 300 MG/5 ML AMPULE has been published 232 times since Apr 13, 2022, and over the history we have for it it has declined 72.4%. The table below summarizes its recorded NADAC range and movement.

Current price$1.0392 per ML
All-time high$3.7654 (May 11, 2022)
All-time low$1.0392 (Nov 18, 2026)
52-week high$1.2618
52-week low$1.0392
Median price$1.6998
Average price$1.7785
Largest weekly change-33.9% (Nov 20, 2024)
Weeks tracked232
Tracking sinceApr 13, 2022

Price History

1W

-1.5%

1M

-4.1%

3M

-4.2%

6M

-4.0%

1Y

-22.6%

3Y

-51.5%

5Y

N/A

All

-72.4%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TOBRAMYCIN 300 MG/5 ML AMPULE?

The current National Average Drug Acquisition Cost (NADAC) for TOBRAMYCIN 300 MG/5 ML AMPULE, manufactured by Lupin Pharmaceuticals Inc., is $1.0392 per ML (NDC 68180096256), effective Nov 18, 2026.

How has the price of TOBRAMYCIN 300 MG/5 ML AMPULE changed over time?

Over the history we have for it, the NADAC for TOBRAMYCIN 300 MG/5 ML AMPULE has declined 72.4%. It has been tracked across 232 weekly CMS publications since Apr 13, 2022.

What are the highest and lowest recorded NADAC prices for TOBRAMYCIN 300 MG/5 ML AMPULE?

Since Apr 13, 2022, the NADAC for TOBRAMYCIN 300 MG/5 ML AMPULE has ranged from a low of $1.0392 (Nov 18, 2026) to a high of $3.7654 (May 11, 2022), with a median of $1.6998 per ML.

Are there cheaper alternatives to TOBRAMYCIN 300 MG/5 ML AMPULE?

7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TOBRAMYCIN 300 MG/5 ML AMPULE in a comparable dosage form, but none are currently priced below it.

Who manufactures TOBRAMYCIN 300 MG/5 ML AMPULE?

TOBRAMYCIN 300 MG/5 ML AMPULE (NDC 68180096256) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.